Wednesday, March 10, 2010
Stem Cell Standard Blog Minimize
Author:Stem Cell StandardCreated:3/24/2009
Learn about our community, upcoming events, and hot topics in stem cell research.

Genetically corrected somatic cells from patients with Fanconi anemia have been reprogrammed to induced pluripotent stem (iPS) cells and subsequently differentiated into haematopoietic progenitors.  

Read More »

Induced pluripotent stem (iPS) cells from a human source have been generated by delivering reprogramming proteins instead of genetic material

Read More »

Draft of NIH guidelines may severely limit the use and funding of current human embryonic stem cell lines

Read More »

New administration promotes new National Institutes of Health (NIH) guidelines for scientists working with human embryonic stem (hES) cells

Read More »

Induced pluripotent stem (iPS) cells have now been generated with no genetic material using instead reprogramming proteins.  

Read More »

Scientists have now generated human induced pluripotent stem (iPS) cells from patients with various diseases. These cells have the potential to advance our understanding of disease development and identify new therapies.

Read More »

Human induced pluripotent stem (iPS) cells have recently been generated with no genetic insertion of reprogramming factors using non-integrating episomal vectors.  

Read More »

Archive Minimize
Search Minimize
Copyright 2009 by Promega Corporation Terms Of UsePrivacy Statement